Standout Papers

Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorecta... 2005 2026 2012 2019 694
  1. Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial (2005)
    Fairooz F. Kabbinavar, Joseph J. Schulz et al. Journal of Clinical Oncology
  2. Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study (2007)
    Charles S. Fuchs, John L. Marshall et al. Journal of Clinical Oncology

Immediate Impact

8 from Science/Nature 79 standout
Sub-graph 1 of 19

Citing Papers

Host–microbiota maladaptation in colorectal cancer
2020 StandoutNature
Dietary modifications for enhanced cancer therapy
2020 StandoutNature
2 intermediate papers

Works of Joseph J. Schulz being referenced

Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study
2007 Standout
Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial
2005 Standout

Author Peers

Author Last Decade Papers Cites
Joseph J. Schulz 1279 256 523 460 8 1.5k
Rafal Wierzbicki 1125 323 831 308 29 1.5k
H. Kröning 1025 173 574 226 26 1.4k
J J Lokich 1361 157 480 229 6 1.6k
Yousif Abubakr 1068 116 480 330 7 1.2k
Cees J. van Groeningen 1265 379 535 323 29 1.7k
Rut Isacson 1256 368 433 205 22 1.9k
Allert H. Vos 1325 259 532 312 11 1.6k
Irmarie Reyes‐Rivera 798 148 697 294 17 1.4k
J Pater 1313 194 555 211 17 1.7k
Ralph Wong 1247 204 392 198 8 1.4k

All Works

Loading papers...

Rankless by CCL
2026